Gemcitabine plus capecitabine in unselected patients with advanced pancreatic cancer.
Affiliation
Department of Medical Oncology, Christie Hospital Foundation Trust, Manchester.Issue Date
2013-04
Metadata
Show full item recordAbstract
Gemcitabine in combination with capecitabine (GEMCAP) is a treatment option for patients with advanced pancreatic cancer (APC), but data are lacking concerning outcomes in unselected patients not enrolled to a randomized trial.Citation
Gemcitabine plus capecitabine in unselected patients with advanced pancreatic cancer. 2013, 42 (3):511-5 PancreasJournal
PancreasDOI
10.1097/MPA.0b013e31826c6aeePubMed ID
23462324Type
ArticleLanguage
enISSN
1536-4828ae974a485f413a2113503eed53cd6c53
10.1097/MPA.0b013e31826c6aee
Scopus Count
Collections
Related articles
- Docetaxel plus gemcitabine in combination with capecitabine as treatment for inoperable pancreatic cancer: a phase II study.
- Authors: Xenidis N, Chelis L, Amarantidis K, Chamalidou E, Dimopoulos P, Courcoutsakis N, Tentes A, Chiotis A, Prassopoulos P, Kakolyris S
- Issue date: 2012 Feb
- Dose finding and early efficacy study of gemcitabine plus capecitabine in combination with bevacizumab plus erlotinib in advanced pancreatic cancer.
- Authors: Starling N, Watkins D, Cunningham D, Thomas J, Webb J, Brown G, Thomas K, Oates J, Chau I
- Issue date: 2009 Nov 20
- Gemcitabine plus capecitabine compared with gemcitabine alone in advanced pancreatic cancer: a randomized, multicenter, phase III trial of the Swiss Group for Clinical Cancer Research and the Central European Cooperative Oncology Group.
- Authors: Herrmann R, Bodoky G, Ruhstaller T, Glimelius B, Bajetta E, Schüller J, Saletti P, Bauer J, Figer A, Pestalozzi B, Köhne CH, Mingrone W, Stemmer SM, Tàmas K, Kornek GV, Koeberle D, Cina S, Bernhard J, Dietrich D, Scheithauer W, Swiss Group for Clinical Cancer Research, Central European Cooperative Oncology Group
- Issue date: 2007 Jun 1
- A phase II study of capecitabine plus gemcitabine in patients with locally advanced or metastatic pancreatic cancer.
- Authors: Song HS, Do YR, Chang HM, Ryu MH, Lee KH, Kim YH, Hong DS, Cho JY, Lee KE, Kim SY
- Issue date: 2008 Oct
- The combination of a chemotherapy doublet (gemcitabine and capecitabine) with a biological doublet (bevacizumab and erlotinib) in patients with advanced pancreatic adenocarcinoma. The results of a phase I/II study.
- Authors: Watkins DJ, Starling N, Cunningham D, Thomas J, Webb J, Brown G, Barbachano Y, Oates J, Chau I
- Issue date: 2014 May